Demand Note dated July 1, 2017

Contract Categories: Business Finance - Note Agreements
EX-10.2 2 ex10-2.htm DEMAND NOTE DATED JULY 1, 2017

 

 

EXHIBIT 10.2

 

DEMAND NOTE

 

4DMED, LTD, a Hong Kong corporation (the “Company,” which term includes any successor entity), for value received promises to pay to 4DMED, Ltd., a Nevada corporation, or its assigns (the “Holder”), the principal sum of FOUR MILLION FIVE HUNDRED THOUSAND DOLLARS ($4,500,000), and to pay interest on the outstanding principal amount of this Note in accordance with Section 1 hereof. All outstanding principal and accrued interest hereunder shall be due and payable on DEMAND. The Holder shall maintain accounts evidencing the date and amount of the loan made hereunder which account shall be prima facie evidence of the amounts due hereunder, provided, however, that the failure to maintain such accounts or any error therein, shall not affect the Company’s obligations to repay (with applicable interest) the amounts loaned by the Holder to the Company hereunder. 

 

Section 1.    Interest; Optional Prepayments

 

This Note shall bear no interest.

 

Section 2.     Method of Payment

 

The Company will pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts to such account free and clear of and without any reduction for any taxes, levies, imports, deduction withholding or charges, and in such manner as the Holder may from time to time direct by written notice. If a payment date is a Saturday, a Sunday or a legal holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Saturday, a Sunday or a legal holiday (a “Business Day”), and interest shall accrue for the intervening period. 

 

Section 3.    Representations and Warranties Intending that the Holder rely upon the following representations and warranties, the Company represents and warrants to the Holder that: 

 

(a) the Company is a Hong Kong corporation duly organized and validly existing in good standing under the laws of its organization and possesses all requisite corporate power and authority to execute, deliver and perform this Note. 

 

(b) The execution, delivery and performance of this Note have been duly authorized by all necessary and appropriate corporate action by and on behalf of the Company. The Note does not conflict with, nor will the execution, delivery or performance of this Note by the Company constitute a breach or default under, or a violation of, any provision of the Company’s articles of incorporation or bylaws or any other agreement, court order, law, rule or regulation to which the Company is a party or by which it or any of its properties may be bound or to which it may be subject. 

1

 

(c) No authorization, approval, waiver or other action to or by, and no notice to or filing with, any governmental agency or authority or regulatory body is required to permit, or is a condition precedent to, the granting of this Note to or for the benefit of the Holder, the execution, delivery or performance of this Note by the Company, or the exercise by the Holder of its rights and remedies hereunder or thereunder. 

 

Section 4.    Waivers; Amendments

 

The Company expressly waives presentment for payment, notice of dishonor, protest, notice of protest, diligence of collection and any other notice of any kind, and hereby consents to any number of renewals or extensions of time of payment hereof, which renewals and extensions shall not affect the liability of any party hereto. No amendment to this Note and no waiver of any provision hereof may be made without the prior written consent of all of the members of the Holder. Any waiver of any kind or character on the part of the Holder in respect of this Note must be in writing and shall be effective only to the extent specifically set forth in such writing. No delay on the part of the Holder in exercising any of its powers or rights, and no partial or single exercise, shall constitute a waiver 

 

Section 5.    Severability

 

If any provision of this Note or the application thereof is held by a court of competent jurisdiction to be invalid or unenforceable, the remaining provisions hereof shall not be affected thereby, and each provision of this Note shall be valid and enforceable to the fullest extent permitted by law. 

 

Section 6.    Notices

 

Any notices or other communications hereunder shall be in writing and shall be deemed to have been duly given if transmitted by facsimile to the number specified below or to a number specified to replace such number. Notices to the Holder shall be given to 4DMED, Ltd. at 4650 Wedekind Rd., Sparks, NV 89431, Telephone: 775 ###-###-####, Facsimile: 775 ###-###-####, Attn: Treasurer.

 

Section 7.    Governing Law; Successors and Assigns

 

This Note shall be deemed a contract under, and shall be governed and construed in accordance with, the laws of the State of Nevada without giving effect to principles of conflicts of laws. The Note shall be binding upon the parties hereto and their respective successors and assigns; provided, however, that the Company may not transfer its interest or obligations hereunder without the consent of the Holder. 

 

[Signatures on following page]

2

 

IN WITNESS WHEREOF, the Company has caused this Note to be signed by its duly authorized officer. 

 

Dated: July 1, 2017 

 

  4DMED, LTD., a Hong Kong corporation
     
  By:

/s/ Yuen May Cheung

 

    Its: Director

3